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VitreoretinalAbstract Background: The purpose of this study was to assess the effect of adding low dose rocuro-
nium to local anesthetic solution on the quality of peribulbar blockade for vitreoretinal (VR) surgery.
Methods: 80 consecutive adult patients scheduled for VR surgery were enrolled in this double-blind
randomized clinical trial. Patients were categorized randomly into 2 equal groups: group C (control
group) received local anesthetic mixture (4 ml lidocaine 2%, 4 ml bupivacaine 0.5%, and hyaluroni-
dase ‘‘30 U/ml”) plus 0.5 ml normal saline, and group S (study group) received the same local anes-
thetic mixture plus 5 mg (0.5 ml) rocuronium. Globe and lid akinesia were assessed 15 min after
injection, and supplemental peribulbar blockade was done in case of inadequate analgesia and or aki-
nesia. Intraoperatively, supplementary sub-Tenon infiltration was performed in case of inadequate
analgesia and/or akinesia. Measurement data included rate of supplementation, analgesic efficacy,
time to first sub-Tenon infiltration, and total anesthetic volume. Major complications, and patient’s
and surgeon’s satisfaction were also recorded.
Results: The adequacy of peribulbar blockade 15 min after injection was comparable in both groups.
Rate of supplementary sub-Tenon infiltrationwas lower in the rocuronium groupwhich is statistically
significant (15 injections versus 53 injections in the control group). Time to first sub-Tenon infiltration
was significantly prolonged in the rocuronium group (90.4 + 11.8 versus 60.2 + 9.2 in the control
group). The total anesthetic volume injected was significantly lower in the rocuronium group (13.2
+ 0.6 versus 20.6 + 0.8 in the control group). There were no major systemic or local complications
in both groups. Patient’s and surgeon’s satisfaction was significantly higher in the rocuronium group.
Conclusion: Adding low dose rocuronium to local anesthetics prolongs duration of peribulbar anes-
thesia and offers an optimal surgical condition without serious adverse effects for patients undergoing
VR surgery.
 2015 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.
Table 1 Scoring system for degree of akinesia.
Ocular movement
Full movement 3
Moderate movement 2
Flicker 1
No movement 0
Eyelid movement
Full movement 2
Flicker 1
No movement 0
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Peribulbar blockade has been widely performed for anterior
segment surgery as it provides the same effect as retrobulbar
anesthesia, but with a lower complications rate [1]. On the
other hand, the lengthy VR surgery that has un-predictable
and uncomfortable nature often necessitates general anesthe-
sia; however, there are many trials proved the safety and effi-
cacy of local anesthesia in this type of surgery [2–4].
Previous studies demonstrated that ophthalmic procedures
more than 2 h duration needed an anesthetic adjuvant and
cannot be performed using the mere standard anesthetics
[5,6]; moreover, it may be necessary to add two adjuvants to
prolong the duration of local anesthetics [7]. Extending the
duration for LA has been also achieved by supplementary
sub-Tenon’s infiltration or indwelling catheter technique in
other studies [8–10].
The efficacy of adding neuromuscular blockers to the stan-
dard LA for anterior segment surgery performed under
peribulbar block has been previously studied [11–15]. To the
best of our knowledge, there were no trials studied the use of
neuromuscular blockers as an adjuvant to the peribulbar
blockade for VR surgery. We hypothesis that, for VR surgery,
adding low dose neuromuscular blocker to the peribulbar LA
solutions may prolong duration, optimize both globe and lid
akinesia and analgesia, and may limit intraoperative sub-
Tenon supplementation.
2. Patient and methods
After obtaining the approval of the local ethical committee,
and Informed written consent from each patient, 80 adult
patients scheduled for VR surgery in Zagazig University
Hospitals of either sex from the beginning of June 2013 to
the end of May 2014 were included in this prospective
double-blind randomized clinical trial. Exclusion criteria
included patients younger than 18 years, patients who refused
local anesthesia, those with single eye, ocular infection, and
when the decubitus position was impossible. Patients with
communication problems, coagulopathy, impaired conscious-
ness, and mental retardation, were also excluded from the
study.
Preoperative investigations in the form of electrocardiogra-
phy (ECG), complete blood picture (CBC), coagulation pro-
file, liver function, kidney function, and biometry were done
for every patient. All patients received no premedications.
In the anesthetic room, an intravenous line was inserted,
basic monitors were applied (5-lead ECG, pulse oximeter,
automated non-invasive blood pressure ‘‘NIBP”), and a nasal
cannula 2 L/min was attached. Monitoring and oxygen ther-
apy were continued for all patients throughout the procedure.
Topical anesthesia of the conjunctiva and cornea was provided
by administering 2–3 drops of Benoxinate hydrochloride
0.4%. Titrated doses of Midazolam 0.5 mg and/or 20 uq fen-
tanyl were administered 5 min before peribulbar injection with
a target to keep the patient calm and cooperative.
Participants were randomly allocated using a closed
envelope into two equal groups according to the type of the
test drug: group C (control group) received a local anesthetic
mixture (4 ml lidocaine 2%, 4 ml bupivacaine 0.5%, and
hyaluronidase ‘‘30 U/ml”) plus 0.5 ml normal saline, andgroup S (study group) received the same standard local anes-
thetic mixture (4 ml lidocaine 2%, 4 ml bupivacaine 0.5%,
and hyaluronidase ‘‘30 U/ml”) plus 5 mg (0.5 ml) rocuronium.
The LA solution used for each patient was revealed by
opening sealing envelopes, and then prepared by the same
nurse anesthetist who drew up the LA mixture and provided
an unlabelled syringe to the same anesthetist who performed
all blocks and were unaware of the LA nature.
After sterilization, the solution study was injected after neg-
ative aspiration using a 27 G 16 mm needle according to the
injection site described by Rizzo et al. [16], percutaneous and
limited superiorly from the inferior lacrimal canaliculus, med-
ian from lateral margin of the nose, laterally from imaginary
perpendicular line that joins the inferior lacrimal papilla to
the inferior margin of the orbit and inferiorly from the inferior
margin of the orbit. The needle was advanced percutaneously
in an anteroposterior direction for half of its length (never
more than 10 ml) and later obliquely in the direction of the
orbital foramen. End points of injection were proptosis, full-
ness of the upper eyelid, or when the globe became subjectively
tense. As soon as the globe became soft, the injection was
started again until the globe becomes tense again. A gentle dig-
ital massage of the eyeball was done for one minute followed
by application of a Hanon balloon inflated to 30 mmH2O
for 15 min.
After removing the balloon, analgesia, ocular and eyelid
movements were evaluated by the same surgeon who was also
blinded to the LA solution used. Analgesia was considered to
be perfect when the patient did not notice any pain on holding
bulbar conjunctiva and lateral rectus muscle insertion. Eyelid
and globe akinesia were assessed by the scoring system
described by Brahama et al. [17] (Table 1); Patients were asked
to squeeze the eye while it is opened in by the surgeon’s hand
(score of 2 if eyelid moves freely, score of 1 if it is flickering
only, and score of 0 if there is no movement). Globe movement
was scored for each direction of gaze with a total sum of 12
(score of 3 = full movement, score of 2 = moderate move-
ment, score of 1 = flicker movement, and score of 0 = no
movement). If the block was inadequate (presence of any sen-
sation, total inability to squeeze the eyelid, or globe movement
score of 2 or more in any direction), a supplementary injection
was performed via the same approach, using 3–6 ml of lido-
caine 2%, and then, the Hanon balloon was reapplied again
for 10 min. If eyelid or globe movements score still more than
2 in any direction, the block was considered to be failed.
If the patient experienced considerable pain and/or the
eyelid and or globe akinesia was inadequate to a degree that
disturbs the operating surgeon, a supplemental lidocaine 2%
Table 2 Patient’s characteristics.
Study group
(n= 40)
Control group
(n= 40)
Age (years) 54 ± 8 52 ± 9
Sex (Male/female) 28/12 26/14
ASA (number)
I 13 15
II 25 22
III 2 3
Duration of surgery
(min.)
144.4 ± 14.4 148.6 ± 15.8
Type of surgery (number)
Vitrectomy 16 14
Retinopexy
+ vitrectomy
11 12
Scleral buckling 13 14
Axial length 24.4 ± 0.8 23.3 ± 0.7
Data presented as mean ± SD or numbers.
Table 3 Adequacy of peribulbar block 15 min post-injection.
Study group
(n= 40)
Control group
(n= 40)
Complete analgesia 40 (100%) 40 (100%)
Globe akinesia score 2 (4) 2 (4)
Eyelid akinesia score 0 0
Primary LA volume (ml) 7.6 ± 0.6 7.8 ± 0.7
Supplementation rate 1 2
LA supplementation
volume (ml)
5 8
Block failure 0 (0%) 0 (0%)
Data presented as mean ± SD, median (range), numbers or
percentage.
Table 4 Sub-Tenon infiltration, and total anesthetic volume.
Study group
(n= 40)
Control group
(n= 40)
Sub-Tenon infiltration
injections
15 53y
Time to first sub-Tenon
infiltration (min)
90.4 ± 11.8 60.2 ± 9.2y
Analgesia adequacy
Grade I 27 9
Grade II 13 31y
Grade III 0 0y
Total volume injected 13.2 ± 0.6 20.6 ± 0.8*
Data presented as mean ± SD or numbers.
*p value < 0.05 = statistical difference.
yp value < 0.001 = high statistical difference.
Adding low dose rocuronium to local anesthetic mixture 203(5–8 ml) was administered by sub-Tenon infiltration by the
surgeon as described by Calenda et al. [8]; A buttonhole was
fashioned through the conjunctiva and the Tenon’s capsule
10 mm posterior to the limbus in the temporal superior quad-
rant, then, the anesthetics delivered using a blunt cannula.
The study parameters were recorded using a data collecting
form by the same anesthetist, who performed all blocks and as
said before,were unaware of the anestheticmixture administered.
Measurement parameters included patient’s characteristics,
duration and type of surgery, efficacy of analgesia, supplemen-
tation rate, time to first sub-Tenon injection, total anesthetic
volume, major complications, patient and surgeon’s satisfac-
tion. The efficacy of analgesia was graded as follows: grade
1-adequate analgesia throughout surgery without any supple-
mentation; grade 2-adequate analgesia with sub-Tenon injec-
tion; and grade 3-inadequate analgesia despite the sub-Tenon
injection [5].
Postoperatively, surgeons assessed the quality of anesthesia
either it was satisfactory or not. Patients were questioned
about their experience intraoperatively either it was comfort-
able, mildly uncomfortable or intensely uncomfortable.
2.1. Statistical analysis
Before carrying out statistical inferential tests, variables were
tested for normal distribution. Normal distribution was
assumed based on graphical presentation of bar charts and val-
ues of skewness and kurtosis – according to descriptive data fea-
ture in SPSS program – between (+1) and (1) for all variables.
All the data collected were fed into Statistical Package for
Social Sciences (SPSS version 19). Data were compared by
using the t-test and expressed as mean ± standard deviation
(Mean ± SD). Scores were presented as median (range). Com-
parison of percentages was performed using the Fisher’s exact
method. P-value of <0.05 was considered as significant, and
P-value of <0001 was considered as highly significant.
3. Results
Itwas found that therewere no significant differences between the
study groups as regards the age, sex and ASA physical status dis-
tribution, duration and type of surgery and axial length (Table 2).
Analgesia and eyelid akinesia were completed at 15 min
after injection for all patients in the study groups. Movement’s
score for globe and lid akinesia was comparable in both
groups. Only one patient in the Rocuronium group and 2
patients in the control group needed a supplementary peribul-
bar injection. Primary and supplementary LA volumes were
also comparable in both groups. No reported cases of failed
peribulbar block in both groups (Table 3).
Efficacy of analgesia is shown in Table 4; Supplementary
sub-Tenon infiltrationwas significantly lower in the rocuronium
group (15 injections versus 53 injections in the control group).
Time to first sub-Tenon supplementation was significantly
longer in the rocuronium group (90.4 ± 11.8 min. versus 60.2
± 9.2 min. in the control group) (P-value < 0.001). 27 patients
in the rocuronium group versus 9 patients in the control group
needed no supplementations, while 13 patients needed a variable
supplementation rate in the rocuronium group versus 31
patients in the control group (P-value < 0.001). There were
no reported cases of inadequate analgesia in both groups.Total LA volume injected (primary peribulbar injection,
peribulbar supplementation, and the subsequent sub-Tenon
infiltration) was 13.2 ± 0.6 in the rocuronium group versus
20.6 ± 0.8 in the control group (p value < 0.001).
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thesia. Major local or systemic complications were not encoun-
tered in this series. Patients’ and surgeon’s satisfaction was
statistically higher in the rocuronium group (p value < 0.001)
(Table 5).
4. Discussion
We found that adding rocuronium 5 mg to LA solutions opti-
mized block and prolonged duration of peribulbar anesthesia
for patients undergoing VR surgery.
Adding small dose of neuromuscular blocker has been
shown to improve efficacy and prolonged duration of neural
blockade that cannot be achieved by the standard local anes-
thetic solution [18,19]. For ophthalmic anesthesia, the exact
mechanism through which non-depolarizing muscle relaxant
improves orbital and eyelid akinesia is not clear; however, it
was explained by the local effects at the muscles motor end-
plate [13]. Moreover, the extra-ocular muscles are so sensitive
to the effect of neuro-muscular blockers as the number of mus-
cle fibers innervated by a single motor neuron is very small [12].
There were many clinical trials that studied the efficacy of
adding neuromuscular blockers as adjuvant to the LA solution
on the adequacy of peribulbar blockade. Two of these studies
used a two injection technique (inferotemporal and medial
injections); Reah et al. [12] who compared 5 ml of 2% ligno-
caine with 1:200,000 adrenaline, 5 ml 0.75 bupivacaine and
150 IU hyaluronidase with either 0.9% saline 0.25, or vecuro-
nium bromide 0.25 ml (5 mg) found that vecuronium improves
the quality of globe and lid akinesia without side effects. More-
over, Kucukyavuz et al. [11], compared 8 mL of a lidocaine–
bupivacaine mixture plus 0.5 mL (5 mg) atracurium without
hyaluronidase and the same amount of the same local anes-
thetic mixture plus 0.5 mL 0.9% NaCL. The time to the onset
of akinesia in minutes was better in the atracurium group;
moreover, they also demonstrated an adequate globe and lid
akinesia. In our study, a single infero-medial injection was
used as it has been established to be more safe and effective
than the two injection technique [20]. This finding was
demonstrated in our study, as the ocular movement sore wasTable 5 Postoperative questionnaire and complications.
Study group
(n= 40)
Control group
(n= 40)
Surgeon satisfaction
Good 11 28y
Satisfactory 13 9*
Unsatisfactory 16 3y
Patient satisfaction
Comfortable 10 35y
Mildly
uncomfortable
22 5y
Intensely
uncomfortable
8 0y
Complications
Local and systemic 0 (%) 0 (%)
Data presented as numbers or percentage.
*p value < 0.05 = statistical difference.
yp value < 0.001 = high statistical difference.comparable, and only three peribulbar supplementations were
recorded in both groups. Also, there were no recorded cases of
failed block.
In another study, the authors used a single inferotemporal
technique. They added rocuronium 0.06 mg/kg to the bupiva-
caine–lidocaine mixture without hyaluronidase. Rocuronium
improved akinesia scores at 2, 5 and 10 min postinjection with
a lower supplementation rate [13].
In the previous 3 studies, neuromuscular blockers were used
as an adjuvant for peribulbar anesthesia for patients undergo-
ing cataract surgery. On the other hand, adding atracurium to
the standard LA shortened the onset time and prolonged the
duration, and provided excellent surgical conditions without
known complications of retrobulbar block in one study [21],
and sub-Tenon in the other [22]. In the current study, we
report the akinesia score only after 15 min peribulbar injection,
so unfortunately we did not study the onset of block in the
study population.
The rate of sub-Tenon infiltration was highly significant in
the Control group (53 injections versus 15 injections in the
Rocuronium group). Calenda et al. [8] reported 15% reinjec-
tion rates (2–3 ml lidocaine 2%) in a series of 300 patients with
1% failure rate; Supplementary sub-Tenon injection (5–8 ml
lidocaine 2%) was 20% in another series that included 141
cases with a 3% failure rate [1]. These two studies had a lower
supplementation rate than our study which may be explained
by the difference in the type and volume of LA and more
importantly the duration of surgery.
As was reported in previous studies [1,15], we did not
encounter cases of retinal ischemia or ischemic optic neuropa-
thy despite the relatively larger volume of injected anesthetic
than used for peribulbar injection for cataract surgery. The
precaution of avoiding anesthetics injection while the globe
was tense was responsible for avoiding these life-threatening
complications. Also, we did not report any major cardiac, res-
piratory, or neurologic adverse effects as was observed in pre-
vious trials [1,2,14].
There were two important limitations in the present study.
The first limitation is the relatively small number of patients;
the second one is that the neuro-muscular tracing was not
monitored in the study populations. The systemic reabsorption
of neuromuscular blocker from peribulbar injection with its
potential risk of muscular weakness as was reported by Allan
[23] still considered an important issue; however, the relatively
large dose of neuromuscular blocker (four times the normal
dose) was responsible for the systemic absorption in his report.
On the other hand, Aissaoui et al. [13] who used a dose of
rocuronium comparable to the present study (0.06 mg/kg)
reported no alteration in the neuromuscular function with
train of four (TOF) monitoring.
So, further study is recommended on a large number of
patients with a close neuromuscular monitoring to confirm
the efficacy and safety of adding neuromuscular blocker to
the standard peribulbar anesthetic solution for patients under-
going VR surgery.5. Conclusion
It can be concluded that, adding low dose rocuronium to local
anesthetic mixture prolongs peribulbar block and provides opti-
mal surgical conditions for patients undergoing VR surgery.
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